Jazz Pharmaceuticals gets FDA approval for cancer therapy

Jazz, which has offices in Philadelphia and Palo Alto, licensed the U.S. marketing rights for the small cell lung cancer treatment in January.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.